E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 5/24/2023 in the Prospect News Distressed Debt Daily.

Lucira Health reports $23.25 million net profit for April

By Sarah Lizee

Olympia, Wash., May 24 – Lucira Health, Inc. reported a $23.25 million net profit for April on $1.21 million of gross income/sales, according to its monthly operating report filed Wednesday with the U.S. Bankruptcy Court for the District of Delaware.

To compare, the company reported a $5.73 million net loss for March on $3.06 million of gross income/sales.

The cash balance at the end of April was $11.83 million, up from $5.82 million at the end of March.

As previously reported, the company closed the sale of its assets to Pfizer Inc. last month. Lucira took in about $17.87 million of proceeds from the sale.

Lucira is a medical technology company based in Emeryville, Calif. The company filed bankruptcy on Feb. 22 under Chapter 11 case number 23-10242.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.